Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06271291 · ClinicalTrials.gov registry record
Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts
A clinical trial of Pancreatic Carcinoma, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- 30,000
- Enrollment target
- 7
- Study locations
NCT06271291 is a study of Pancreatic Carcinoma that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30,000 participants, above the 1,818-participant average among 18 other Pancreatic Carcinoma trials with a reported enrollment target (1550% higher). The trial reports 7 study locations across 7 states.
The verdict
NCT06271291, a study of Pancreatic Carcinoma, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- 30,000 participants
- Enrollment target
- 7
- Study locations
Study Summary
This study evaluates individuals without pancreatic cancer, but who have been determined to be at higher-than-average lifetime risk of developing pancreatic cancer to help detect pancreatic cancer or other cancers at an earlier time when they might be more easily treated and cured.
Conditions Studied
Interventions
- OTHER Non-Interventional Study
Study Locations (7)
Arizona
- HonorHealth Research Institute - Scottsdale
Georgia
- Piedmont Healthcare - Atlanta
Illinois
- OSF Saint Francis Medical Center - Peoria
Minnesota
- Mayo Clinic in Rochester - Rochester
Nebraska
- University of Nebraska Medical Center - Omaha
Oregon
- Oregon Health & Science University - Portland
Pennsylvania
- University of Pittsburgh - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30,000 participants |
| Start Date | 2024-12-12 |
| Est. Completion | 2029-11-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06271291
The ClinicalTrials.gov registry entry for NCT06271291 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 30,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,818-participant average among 18 other Pancreatic Carcinoma trials with a reported enrollment target (1550% higher). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Pancreatic Carcinoma appearing as the primary indexed condition, and to 1 intervention - of which Non-Interventional Study is the first listed.
NCT06271291 reports 7 study locations spanning 7 distinct geographic areas - top geographies include Arizona, Georgia, Illinois.
Frequently Asked Questions
What is clinical trial NCT06271291 about?
NCT06271291 is a clinical study titled "Pancreatic Cancer Detection Consortium (PCDC) Prospective Cohorts". This study evaluates individuals without pancreatic cancer, but who have been determined to be at higher-than-average lifetime risk of developing pancreatic cancer to help detect pancreatic cancer or other cancers at an earlier time when they might be more easily treated and cured.
What is the current status of trial NCT06271291?
This trial is currently recruiting. The enrollment target is 30,000 participants. The study started on 2024-12-12. Estimated completion is 2029-11-01.
What conditions does trial NCT06271291 study?
This clinical trial studies the following conditions: Pancreatic Carcinoma.
What interventions are being tested in trial NCT06271291?
The interventions under investigation include: Non-Interventional Study (OTHER).
Who is sponsoring clinical trial NCT06271291?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06271291 being conducted?
This trial has 7 study locations across Arizona, Georgia, Illinois, Minnesota, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pancreatic Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
RECRUITING · Phase 3
-
Pilot Study of Pancreatic Cancer Screening
RECRUITING
-
Use Of Indocyanine Green In Pancreas Surgery
RECRUITING
-
A Study of MGC028 in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
Pancreatic Cancer Detection Consortium
RECRUITING
-
Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.